HANNAH PLUEGER: Open Payments
NPI 1225469760 · SILVERDALE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 48 payments from 12 companies in 2025. Trend: 2023 $1,715 · 2024 $1,028 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $315 |
| Abbott Laboratories | 9 | $238 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 18 | $151 |
| Alnylam Pharmaceuticals Inc. | 1 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 1 | $101 |
| Penumbra, Inc. | 2 | $63 |
| Medtronic, Inc. | 2 | $62 |
| Edwards Lifesciences Corporation | 1 | $34 |
| Boston Scientific Corporation | 1 | $21 |
Products named: CAMZYOS, CARDIOMEMS, LifeVest, AMVUTTRA, JARDIANCE, WAINUA, Penumbra System, REVEAL LINQ.
Industry payments across WA — which companies pay providers there.
